Inovio Ev To Operating Cash Flow from 2010 to 2024
| INO Stock | USD 4.32 0.13 3.10% |
EV To Operating Cash Flow | First Reported 2010-12-31 | Previous Quarter (1.22) | Current Value (1.28) | Quarterly Volatility 145.22955619 |
Check Inovio Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Inovio Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.4 M, Interest Expense of 1.2 M or Total Revenue of 790.4 K, as well as many indicators such as Price To Sales Ratio of 155, Dividend Yield of 1.0E-4 or PTB Ratio of 1.1. Inovio financial statements analysis is a perfect complement when working with Inovio Pharmaceuticals Valuation or Volatility modules.
Inovio | Ev To Operating Cash Flow |
Latest Inovio Pharmaceuticals' Ev To Operating Cash Flow Growth Pattern
Below is the plot of the Ev To Operating Cash Flow of Inovio Pharmaceuticals over the last few years. It is a valuation metric comparing the company's enterprise value to its operating cash flow, indicating how many dollars of EV are generated for each dollar of operating cash flows. Inovio Pharmaceuticals' EV To Operating Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Inovio Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Ev To Operating Cash Flow | 10 Years Trend |
|
Ev To Operating Cash Flow |
| Timeline |
Inovio Ev To Operating Cash Flow Regression Statistics
| Arithmetic Mean | (100.32) | |
| Coefficient Of Variation | (144.77) | |
| Mean Deviation | 106.01 | |
| Median | (36.23) | |
| Standard Deviation | 145.23 | |
| Sample Variance | 21,092 | |
| Range | 436 | |
| R-Value | 0.49 | |
| Mean Square Error | 17,362 | |
| R-Squared | 0.24 | |
| Significance | 0.07 | |
| Slope | 15.76 | |
| Total Sum of Squares | 295,283 |
Inovio Ev To Operating Cash Flow History
About Inovio Pharmaceuticals Financial Statements
Inovio Pharmaceuticals investors utilize fundamental indicators, such as Ev To Operating Cash Flow, to predict how Inovio Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| EV To Operating Cash Flow | (1.22) | (1.28) |
Check out the analysis of Inovio Pharmaceuticals Correlation against competitors. To learn how to invest in Inovio Stock, please use our How to Invest in Inovio Pharmaceuticals guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inovio Pharmaceuticals. If investors know Inovio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inovio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.43) | Revenue Per Share 0.025 | Quarterly Revenue Growth (0.55) | Return On Assets (0.40) | Return On Equity (0.91) |
The market value of Inovio Pharmaceuticals is measured differently than its book value, which is the value of Inovio that is recorded on the company's balance sheet. Investors also form their own opinion of Inovio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Inovio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inovio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Inovio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inovio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Inovio Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inovio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.